Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

LNSR - LENSAR, Inc.

IEX Last Trade
8.61
0   0%

Share volume: 502
Last Updated: Thu 26 Dec 2024 06:38:29 PM CET
Surgical and Medical Instrument Manufacturing : 1.09%

PREVIOUS CLOSE
CHG
CHG%
$8.61
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
7%
Profitability 0%
Dept financing 15%
Liquidity 52%
Performance 1%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0.46%
1 Month
16.80%
3 Months
97.05%
6 Months
97.95%
1 Year
162.54%
2 Year
221.85%
Key data
Stock price
$8.61
P/E Ratio 
-4.32
DAY RANGE
$8.60 - $8.61
EPS 
-$1.11
52 WEEK RANGE
$3.16 - $9.23
52 WEEK CHANGE
$167.38
MARKET CAP 
54.211 M
YIELD 
N/A
SHARES OUTSTANDING 
11.608 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
BETA 
0.56
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$60,946
AVERAGE 30 VOLUME 
$47,425
Company detail
CEO: Nicholas T. Curtis
Region: US
Website: lensar.com
Employees: 110
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

LENSAR, Inc. focuses on developing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. The company was incorporated in 2004 and is headquartered in Orlando, Florida.

Recent news